
Scientific Reports, Год журнала: 2024, Номер 14(1)
Опубликована: Ноя. 22, 2024
The increasing occurrence of hospital-associated infections, particularly bacteremia, caused by extensively drug-resistant (XDR) carbapenemase-producing colistin-resistant Klebsiella pneumoniae highlights a critical requirement to discover new therapeutic alternatives. Bacteriophages having host-specific bacteriolytic effects are promising alternatives for combating these pathogens. Among 12 phages isolated from public wastewater in Thailand, two phages-vB_kpnM_05 (myovirus) and vB_kpnP_08 (podovirus) showed broad-host range, producing activities against 81.3% (n = 26) 78.1% 25) 32 XDR K. pneumoniae, with capsular types—K15, K17, K50, K51, K52/wzi-50 K2/wzi-2. Both short replication times, large burst sizes rapid adsorptions. They exhibited significant stability under various environmental conditions. Genomic analysis revealed that both genetically distinct Myoviridae Podoviridae family, the lack toxin, virulence, lysogeny antibiotic resistance genes. These characteristics highlighted their potential utilizing phage therapy pneumoniae. Although cocktail combining vB_kpnM_05 provided bacteriolysis longer duration (8 h) than its monophage (6 h), bacterial regrowth was observed which suggested an evitable development phages' selection pressures. Future study will be undertaken elucidate precise mechanisms developed associated fitness cost. Remarkably, amikacin at sub-inhibitory concentrations produced potent synergy completely suppressing vitro. Our demonstrated prophylactic effectiveness cocktail-amikacin combination as alternative strategy overcoming bacteremia carbapenemase colistin vivo.
Язык: Английский